Forfivo XL FDA Approval History
FDA Approved: Yes (First approved November 10, 2011)
Brand name: Forfivo XL
Generic name: bupropion hydrochloride
Dosage form: Extended Release Tablets
Company: IntelGenx Corp.
Treatment for: Depression
Forfivo XL (bupropion) is a high-strength formulation of the aminoketone antidepressant bupropion (contained in Wellbutrin) indicated for the treatment of major depressive disorder.
Development timeline for Forfivo XL
| Date | Article |
|---|---|
| Nov 11, 2011 | Approval IntelGenx Announces FDA Approval of its High Dose Anti-Depressant Forfivo XL |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
